Cingulate Inc. Share Price
CINGCingulate Inc. Stock Performance
Open $3.96 | Prev. Close $4.02 | Circuit Range N/A |
Day Range $3.96 - $4.07 | Year Range $3.23 - $5.97 | Volume 1,215 |
Average Traded $4.00 |
Cingulate Inc. Share Price Chart
About Cingulate Inc.
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
24-Dec-25 | $3.96 | $3.97 | +0.00% |
24-Dec-25 | $3.96 | $3.97 | -1.22% |
23-Dec-25 | $4.05 | $4.02 | -3.97% |
22-Dec-25 | $3.91 | $4.18 | +5.55% |
19-Dec-25 | $3.84 | $3.96 | +2.19% |
18-Dec-25 | $3.96 | $3.88 | +1.31% |
17-Dec-25 | $3.99 | $3.83 | -2.05% |
FAQs on Cingulate Inc. Share Price
Can I buy Cingulate Inc. shares in India?
What is the share price of Cingulate Inc.?
What is the 5 year returns of Cingulate Inc.?
What are the high & low stock price of Cingulate Inc. today?
What is the 52-week high and low of Cingulate Inc. stock?